Literature DB >> 18000802

Predicting survival for men with clinically localized prostate cancer: what do we need in contemporary practice?

Peter Albertsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18000802     DOI： 10.1002/cncr.23107

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  9 in total

1.  Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.

Authors:  Peng Ru; Robert Steele; Pratibha V Nerurkar; Nancy Phillips; Ratna B Ray
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-12

2.  Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.

Authors:  Jia-Xuan Qiu; Zhi-Wei Zhou; Zhi-Xu He; Ruan Jin Zhao; Xueji Zhang; Lun Yang; Shu-Feng Zhou; Zong-Fu Mao
Journal:  Drug Des Devel Ther       Date:  2015-01-07       Impact factor: 4.162

3.  Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.

Authors:  Bilal Bin Hafeez; Joseph W Fischer; Ashok Singh; Weixiong Zhong; Ala Mustafa; Louise Meske; Mohammad Ozair Sheikhani; Ajit Kumar Verma
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-27

4.  Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model.

Authors:  Bilal Bin Hafeez; Weixiong Zhong; Joseph W Fischer; Ala Mustafa; Xudong Shi; Louise Meske; Hao Hong; Weibo Cai; Thomas Havighurst; Kyungmann Kim; Ajit K Verma
Journal:  Mol Oncol       Date:  2012-12-14       Impact factor: 6.603

5.  Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers.

Authors:  Bilal Bin Hafeez; Weixiong Zhong; Ala Mustafa; Joseph W Fischer; Olya Witkowsky; Ajit K Verma
Journal:  Carcinogenesis       Date:  2012-09-13       Impact factor: 4.944

6.  What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models.

Authors:  Roman Gulati; Elisabeth M Wever; Alex Tsodikov; David F Penson; Lurdes Y T Inoue; Jeffrey Katcher; Shih-Yuan Lee; Eveline A M Heijnsdijk; Gerrit Draisma; Harry J de Koning; Ruth Etzioni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05       Impact factor: 4.254

7.  PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer.

Authors:  Shijie Yang; Qiuyang Zhang; Sen Liu; Alun R Wang; Zongbing You
Journal:  Am J Clin Exp Urol       Date:  2016-01-28

Review 8.  Emerging Themes in Image Informatics and Molecular Analysis for Digital Pathology.

Authors:  Rohit Bhargava; Anant Madabhushi
Journal:  Annu Rev Biomed Eng       Date:  2016-07-11       Impact factor: 9.590

9.  Identification of Potential Key Genes in Prostate Cancer with Gene Expression, Pivotal Pathways and Regulatory Networks Analysis Using Integrated Bioinformatics Methods.

Authors:  Mohd Mabood Khan; Mohammad Taleb Mohsen; Md Zubbair Malik; Sali Abubaker Bagabir; Mustfa F Alkhanani; Shafiul Haque; Mohammad Serajuddin; Mausumi Bharadwaj
Journal:  Genes (Basel)       Date:  2022-04-08       Impact factor: 4.141
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.